EPO Board of Appeal issues communication on BI CRISPR/Cas9 patent hearing
04-11-2019
EPO grants second CRISPR patent to ERS Genomics
07-03-2018
vchal / iStockphoto.com
The Broad Institute of Harvard and MIT has said it will appeal against a decision by the European Patent Office (EPO) to revoke one of its patents covering CRISPR/Cas9 technology.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Broad Institute, CRISPR, patent revocation, EPO, European Patent Office
